IP Verse

Catalyst Pharmaceuticals, Inc. V. Teva Pharmaceuticals, Inc. - 2:23-cv-01190

Explore the details of the Catalyst Pharmaceuticals, Inc. V. Teva Pharmaceuticals, Inc. case under case number 2:23-cv-01190 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
2:23-cv-01190
Filing Date
Mar 1, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
TEVA PHARMACEUTICAL INDUSTRIES LIMITED -
SERB SA -
CATALYST PHARMACEUTICALS, INC. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 15, 2024Set Deadlines as to 140 MOTION for Leave to Appear Pro Hac Vice . Motion set for 8/19/2024 before Magistrate Judge Jose R. Almonte. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (mxw, )PACER Document
Jul 17, 2024Pro Hac Vice counsel, ANDREW Z. BARNETT, has been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (mxw, )PACER Document
Aug 12, 2024TEXT ORDER: A status conference is scheduled for August 20, 2024, at 4:00 p.m. For the conference, please dial 973-437-5535 and enter Phone conference ID: 577 551 351#. The purpose of the conference is to discuss whether, in light of recent developments in the cases, the Court still needs to decide (1) Lupin's motion to compel Plaintiffs to supplement their infringement contentions (ECF No. 80 in the Lupin Action), (2) the parties' competing motions to strike Markman Hearing submissions, and (3) the discovery dispute raised at ECF No. 161 in the Lupin action. So Ordered by Magistrate Judge Jose R. Almonte on 8/12/2024. (akw, ) (Entered: 08/12/2024)PACER Document
Aug 20, 2024Minute Entry for proceedings held before Magistrate Judge Jose R. Almonte. A status conference was held on August 20, 2024. The parties discussed the recent developments in the case and the outstanding motions the Court is still considering. (akw, )PACER Document
Nov 12, 2024TEXT ORDER: Oral argument on the appeal at ECF 125 will take place in person on November 22 at 10:00am. So Ordered by Judge Michael E. Farbiarz on 11/12/2024. (ro, ) (Entered: 11/12/2024)PACER Document
Nov 19, 2024TEXT ORDER: The Court is in receipt of the parties' letter (ECF No. 161 ) with their positions regarding the scheduling of additional Markman expert discovery. The parties shall proceed with discovery as follows: Expert depositions related to Markman shall be completed by December 13, 2024. Supplemental claim construction briefs shall be due by December 23, 2024. So Ordered by Magistrate Judge Jose R. Almonte on 11/19/2024. (akw, ) (Entered: 11/20/2024)PACER Document
Nov 22, 2024TEXT ORDER: The appeal [ECF 125] is denied. The decision of United States Magistrate Judge Almonte [ECF 116] is affirmed for the reasons set out during oral argument on November 22, 2024. So Ordered by Judge Michael E. Farbiarz on 11/22/2024. (ro, ) (Entered: 11/22/2024)PACER Document
Nov 22, 2024TEXT ORDER: The Defendants' request to defer findings on indefiniteness [ECF 52 & 160] is denied. Parties shall proceed with the discovery related to indefiniteness as ordered at ECF 157 & 162. So Ordered by Judge Michael E. Farbiarz on 11/22/2024. (ro, ) (Entered: 11/22/2024)PACER Document
Dec 23, 2024DECLARATION of Lauren Watt re 168 Markman Response Brief,, by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Exhibit 40)(CHEVALIER, CHARLES) (Entered: 12/23/2024)PACER Document
Dec 23, 2024MARKMAN RESPONSE BRIEF re 66 Markman Opening Brief, (Attachments: # 1 Exhibit 39)(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 12/23/2024)PACER Document
Dec 23, 2024RESPONSE re 157 Order, Terminate Motions. (Attachments: # 1 Declaration of Brian L. O'Gara in Support of Defendants' Additional Responsive Claim Construction Brief, # 2 Exhibit 26 (Deposition Transcript of Charlene McQueen, Ph.D.))(ABRAHAM, ERIC)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 12/23/2024)PACER Document
Jan 6, 2025REDACTION to 168 Markman Response Brief,, by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Exhibit 39)(CHEVALIER, CHARLES) (Entered: 01/06/2025)PACER Document
Jan 6, 2025REDACTION to 167 Response (NOT Motion),, by CATALYST PHARMACEUTICALS, INC., SERB SA. (CHEVALIER, CHARLES) (Entered: 01/06/2025)PACER Document
Jan 6, 2025MOTION to Seal ECF Nos. 167, 168, and 168-1 by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # 1 Declaration of Charles H. Chevalier, # 2 Index, # 3 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 01/06/2025)PACER Document
Jan 7, 2025ORDER granting 170 Motion to Seal. Signed by Magistrate Judge Jose R. Almonte on 1/7/2025. (adc) (Entered: 01/07/2025)PACER Document
Jan 8, 2025Letter from Charles H. Chevalier to The Honorable Michael E. Farbiarz, U.S.D.J. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 01/08/2025)PACER Document
Jan 8, 2025Letter from Charles H. Chevalier to The Honorable Michael E. Farbiarz, U.S.D.J. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 01/08/2025)Attachment
Jan 10, 2025CONSENT JUDGMENT in favor of CATALYST PHARMACEUTICALS, INC., SERB SA against TEVA PHARMACEUTICALS USA, INC.; CIVIL CASE TERMINATED. Signed by Judge Michael E. Farbiarz on 1/10/2025. (mxw, ) (Entered: 01/10/2025)PACER Document
Jan 7, 2025Set Deadlines as to 170 MOTION to Seal ECF Nos. 167, 168, and 168-1. Motion set for 2/3/2025 before Magistrate Judge Jose R. Almonte. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (wh)PACER Document